Hicham MAJD, PhD is working in Device Development & Commercialization (DD&C) at Novartis Pharma AG as Device Project Leader New Technologies leading early stage projects (Ophthalmology and Cell & Gene Therapy). Hicham has received his Master degree in Micro-Engineering and his PhD in Biotechnology and Bioengineering at EPFL, Switzerland and Business Certificate from Babson College, USA.
Hicham has a proven track record in technology innovation, with already multiple international patents, scientific publications and one book chapter. During his career, Hicham leads device development in medical and no medical fields from idea to commercialization. Hicham developed and managed of novel bioreactor for cell culture that increases by 10-folds cell growth and preserves stem cells pluripotency.
Hicham worked at Helbling Technik Bern AG as specialist in bioengineering and material sciences. He founded and managed labseed SA, start-up developing a novel surface treatment for implantable device to improve the biocompatibility and bio-integration.